首页> 美国卫生研究院文献>Pharmaceutics >Development of Multifunctional Liposomes Containing Magnetic/Plasmonic MnFe2O4/Au Core/Shell Nanoparticles
【2h】

Development of Multifunctional Liposomes Containing Magnetic/Plasmonic MnFe2O4/Au Core/Shell Nanoparticles

机译:含磁性/电性MnFe2O4 / Au核/壳纳米粒子的多功能脂质体的开发

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Multifunctional liposomes containing manganese ferrite/gold core/shell nanoparticles were developed. These magnetic/plasmonic nanoparticles were covered by a lipid bilayer or entrapped in liposomes, which form solid or aqueous magnetoliposomes as nanocarriers for simultaneous chemotherapy and phototherapy. The core/shell nanoparticles were characterized by UV/Visible absorption, X-Ray Diffraction (XRD), Transmission Electron Microscopy (TEM), and Superconducting Quantum Interference Device (SQUID). The magnetoliposomes were characterized by Dynamic Light Scattering (DLS) and TEM. Fluorescence-based techniques (FRET, steady-state emission, and anisotropy) investigated the incorporation of a potential anti-tumor drug (a thienopyridine derivative) in these nanosystems. The core/shell nanoparticles exhibit sizes of 25 ± 2 nm (from TEM), a plasmonic absorption band (λmax = 550 nm), and keep magnetic character. XRD measurements allowed for the estimation of 13.3 nm diameter for manganese ferrite core and 11.7 nm due to the gold shell. Aqueous magnetoliposomes, with hydrodynamic diameters of 152 ± 18 nm, interact with model membranes by fusion and are able to transport the anti-tumor compound in the lipid membrane, with a high encapsulation efficiency (EE (%) = 98.4 ± 0.8). Solid magnetoliposomes exhibit hydrodynamic diameters around 140 nm and also carry successfully the anticancer drug (with EE (%) = 91.2 ± 5.2), while also being promising as agents for phototherapy. The developed multifunctional liposomes can be promising as therapeutic agents for combined chemo/phototherapy.
机译:开发了含有锰铁氧体/金核/壳纳米粒子的多功能脂质体。这些磁性/等离子体纳米颗粒被脂质双层覆盖或被脂质体包裹,脂质体形成固体或水性磁脂质体作为纳米载体,用于同时进行化学疗法和光疗。核/壳纳米颗粒的特征在于紫外线/可见光吸收,X射线衍射(XRD),透射电子显微镜(TEM)和超导量子干涉仪(SQUID)。磁脂质体的特征在于动态光散射(DLS)和TEM。基于荧光的技术(FRET,稳态发射和各向异性)研究了在这些纳米系统中掺入潜在的抗肿瘤药物(噻吩并吡啶衍生物)的方法。核/壳纳米粒子的尺寸为25±2 nm(来自TEM),具有等离子体吸收带(λmax= 550 nm),并保持磁性。 XRD测量可以估算出锰铁氧体磁芯的直径为13.3 nm,而金壳则为11.7 nm。流体动力学直径为152±18 nm的磁脂质体通过融合与模型膜相互作用,并能够以高包封效率(EE(%)= 98.4±0.8)在脂质膜中转运抗肿瘤化合物。固体脂质体的流体动力学直径约为140 nm,并且还成功携带抗癌药物(EE(%)= 91.2±5.2),同时也有望用作光疗剂。研发的多功能脂质体有望成为联合化学/光疗的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号